summit study tirzepatide Interplay of Chronic Kidney Disease and the Effects of in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The Trial Impact of Obesity Severity on

However, newer medications target multiple metabolic hormones: GLP-1 drugs (single-hormone): semaglutide medications like Wegovy and Ozempic Dual-agonist drugs: tirzepatide medications like Mounjaro and Zepbound (target GLP-1 and GIP receptors) Triple-agonist drugs: retatrutide (targets GLP-1, GIP and glucagon receptors) Researchers believe stimulating multiple hormone pathways may produce stronger effects on appetite, metabolism and energy expenditure

Klinic provides access to tirzepatide, also known as Zepbound, a groundbreaking weight loss medication

Prescription renewal process Private Wegovy prescriptions are reviewed and renewed at regular intervals in accordance with GMC and MHRA prescribing guidance

Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner